Effectiveness of Recruitment Strategies of Latino Smokers: Secondary Analysis of a Mobile Health Smoking Cessation Randomized Clinical Trial

[ad_1]


Background:

Latinos remain disproportionately underrepresented in clinical trials, comprising only 2%-3% of research participants. In order to address health disparities, it is critically important to increase enrollment of Latino smokers in smoking cessation trials. There is limited research examining effective recruitment strategies for this population.


Objective:

The purpose of this study was to compare the effectiveness of direct versus mass and high- versus low-effort recruitment strategies on recruitment and retention of Latino smokers to a randomized smoking cessation trial. We also examine how the type of recruitment might have influenced the characteristics of enrolled participants.


Methods:

Latino smokers were enrolled into Decídetexto from 4 states-New Jersey, Kansas, Missouri, and New York. Participants were recruited from August 2018 until March 2021. Mass recruitment strategies included English and Spanish advertisements to the Latino community via flyers, Facebook ads, newspapers, television, radio, church bulletins, and our Decídetexto website. Direct, high-effort strategies included referrals from clinics or community-based organizations with whom we partnered, in-person community outreach, and patient registry calls. Direct, low-effort strategies included texting or emailing pre-existing lists of patients who smoked. A team of trained bilingual (English and Spanish) recruiters from 9 different Spanish-speaking countries of origin conducted recruitment, assessed eligibility, and enrolled participants into the trial.


Results:

Of 1112 individuals who were screened, 895 (80.5%) met eligibility criteria, and 457 (457/895, 51.1%) enrolled in the trial. Within the pool of screened individuals, those recruited by low-effort recruitment strategies (both mass and direct) were significantly more likely to be eligible (odds ratio [OR] 1.67, 95% CI 1.01-2.76 and OR 1.70, 95% CI 0.98-2.96, respectively) and enrolled in the trial (OR 2.60, 95% CI 1.81-3.73 and OR 3.02, 95% CI 2.03-4.51, respectively) compared with those enrolled by direct, high-effort strategies. Among participants enrolled, the retention rates at 3 months and 6 months among participants recruited via low-effort strategies (both mass and direct) were similar to participants recruited via direct, high-effort methods. Compared with enrolled participants recruited via direct (high- and low-effort) strategies, participants recruited via mass strategies were less likely to have health insurance (44.0% vs 71.2% and 71.7%, respectively; P<.001), lived fewer years in the United States (22.4 years vs 32.4 years and 30.3 years, respectively; P<.001), more likely to be 1st generation (92.7% vs 76.5% and 77.5%, respectively; P=.007), more likely to primarily speak Spanish (89.3% vs 65.8% and 66.3%, respectively), and more likely to be at high risk for alcohol abuse (5.8 mean score vs 3.8 mean score and 3.9 mean score, respectively; P<.001).


Conclusions:

Although most participants were recruited via direct, high-effort strategies, direct low-effort recruitment strategies yielded a screening pool more likely to be eligible for the trial. Mass recruitment strategies were associated with fewer acculturated enrollees with lower access to health services-groups who might benefit a great deal from the intervention.


Trial registration:

ClinicalTrials.gov identifier: NCT03586596; https://clinicaltrials.gov/ct2/show/NCT03586596.


International registered report identifier (irrid):

RR2-DOI: 10.1016/j.cct.2020.106188.


Keywords:

Latino health, Latino recruitment; health disparities; participant recruitment; smoking cessation.

[ad_2]

Source link

Trending Topics

Features

Download and distribute powerful vaccination QI resources for your community.

Sign up now to support health equity and sustainable health outcomes in your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.

The single most important purpose of our healthcare system is to reduce patient risk for an acute event.

Related Posts
How NMQF Advances Minority Health Through Data, Research and Health Access
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs
Scroll to Top
Featured Articles
How NMQF Advances Minority Health Through Data, Research and Health Access
How NMQF Advances Minority Health Through Data, Research and Health Access
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks o...
The Communities Most Burdened by Disease Should Be the First to Benefit from Artificial Intelligence
The Communities Most Burdened by Disease Should Be the First to Benefit from ...
Cancer Pain Care Access Gap Hits Black, Asian Patients
Black and Asian Cancer Patients Wait Longer for Pain Relief in New Study
What Is Cyclosporiasis Symptoms, Food Safety, and Reasons
What Is Cyclosporiasis? The Foodborne Illness Showing Up in the News
Categories
AI
ATTR-CM
BIPOC News
Cancer
Clinical Trials
Covid19
Diseases of the Body
Environment
Health Data
Health Equity Events
Health Policy
Health Tips
Subscribe to our newsletter to receive our latest news​
All Stories
How NMQF Advances Minority Health Through Data, Research and Health Access
How NMQF Advances Minority Health Through Data, Research and Health Access
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks o...
BIPOC News
How NMQF Advances Minority Health Through Data, Research and Health Access
How NMQF Advances Minority Health Through Data, Research and Health Access
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
The Communities Most Burdened by Disease Should Be the First to Benefit from Artificial Intelligence
The Communities Most Burdened by Disease Should Be the First to Benefit from ...
Environment
UV Safety Awareness Month Raises Urgency on Skin Cancer Prevention and Sun Protection Equity
UV Safety Awareness Month Raises Urgency on Skin Cancer Prevention and Sun Pr...
Extreme Heat Safety Tips 5 Ways to Protect Your Health This Summer fyh.news
5 Heat Safety Tips That Could Protect Your Health This Summer
Lupus Awareness Event in Baltimore Aims to Support Research and Shine a Light on Health Disparities
Lupus Awareness Event in Baltimore Aims to Support Research and Shine a Light...
Work Force
A multigenerational Black and Hispanic family sitting together in a park, showing how Social Security helps support older adults, people with disabilities, and families across generations.
Millions of Older Americans Could Face Smaller Social Security Checks by 2032...
dreamstime_s_243253251
The Caregiver Journey: The Hidden Backbone of American Healthcare
Families gather at a Bronx community festival with live music, kids’ activities, and health booths sharing SOMOS social care resources and free screenings.
Celebrating Hispanic heritage while learning about health care

[xyz-ips snippet=”Output-Source-Name”]

Clinical Trials
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Early Cancer Detection Is Entering a New Era. Flint Is Helping Lead the Way.
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks o...
Clinical Trial Diversity Remains a Critical Challenge in Alzheimer’s Research
Clinical Trial Diversity Remains a Critical Challenge in Alzheimer’s Research
Vaccines and Outbreaks
A parent checking a child's temperature during summer, illustrating the changing RSV patterns and year-round respiratory virus risks.
Can You Get RSV During the Summer?
Michelle Lam, MBA, of NYC Health + Hospitals/Elmhurst & Amy Harris of NYC Health + Hospitals/Elmhurst
Healthcare Leaders Spotlight Vaccine Equity and Adult Immunization Strategies...
Measles Outbreaks Surge: Essential Facts and Prevention Strategies
Measles Outbreaks Surge: Essential Facts and Prevention Strategies
Other Categories
AI
Read the latest AI News stories trending around the world
ATTR-CM
Cancer
Read the latest Cancer stories trending around the world
Covid19
Diseases of the Body
Read about the latest Diseases of the Body trending around the world
Friday Webinars
Every Friday, we bring you insightful webinars covering critical topics in healthcare, data equity, and policy reform.
Health Data
Read the latest Health Data stories trending around the world
Health Equity Events
Read the best Health Equity Events around the country.
Health Policy
Read the latest Health Policy stories trending around the world
Health Tips
Heart Health
Read the latest on Heart Health News, Stories and Tips.
kidney Health
Read more trending News about Kidney Health, Stories and Tips.